Angene Chemical
Draw
|
Currency :
Home Products

AG01A3K0

33386-08-2 | Buspirone hydrochloride

Chemical structure of Buspirone hydrochloride, CAS 33386-08-2
AG01A3K0
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 33386-08-2
Catalog Number AG01A3K0(AGN-PC-0R8Y0E)
Chemical Name Buspirone hydrochloride
EC Number 251-489-4
IUPAC Name 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride
InChI InChI=1S/C21H31N5O2.ClH/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20;/h5,8-9H,1-4,6-7,10-17H2;1H
InChI Key RICLFGYGYQXUFH-UHFFFAOYSA-N
MDL Number MFCD00078569
Molecular Formula C21H32ClN5O2
Molecular Weight 421.9641
SMILES c1cnc(nc1)N2CCN(CC2)CCCCN3C(=O)CC4(CCCC4)CC3=O.Cl
UNII 207LT9J9OC
Synonyms
Anxut, Apo Buspirone, Apo-Buspirone, Bespar, Busp, Buspar, Buspirone, Buspirone Hydrochloride, Gen Buspirone, Gen-Buspirone, Hydrochloride, Buspirone, Lin Buspirone, Lin-Buspirone, MJ 9022 1, MJ-9022-1, MJ90221, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide, Neurosine, Novo Buspirone, Novo-Buspirone, Nu Buspirone, Nu-Buspirone, PMS Buspirone, PMS-Buspirone, ratio Buspirone, ratio-Buspirone, Buspirone hydrochloride, 33386-08-2, Buspar, Buspirone HCL, Narol, Buspimen, Ansitec, Anxinil, Anxiolan, Busirone, Buspinol, Censpar, Effiplen, Establix, Kallmiren, Lucelan, Mabuson, Normaton, Spamilan, Barpil, Bespar, Itagil, Nerbet, Sburol, Travin, Tutran, Biron, Relac, Apo-Buspirone, Buspirone (hydrochloride), UNII-207LT9J9OC, EINECS 251-489-4, 8-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione hydrochloride, MJ 9022-1, MLS000069796, 207LT9J9OC, CHEBI:3224, Ansiced, Axoren, MFCD00078569, N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-1,1-cyclopentanediacetamide monohydrochloride, N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride, SMR000058186, 1,1-Cyclopentanediacetimide, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, hydrochloride, 8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione hydrochloride, 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride, 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione hydrochloride, C21H32ClN5O2, 8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione monohydrochloride, 8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, monohydrochloride, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione, SR-01000075541, buspirone-HCl, Buspirone hydrochloride [USAN], 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride, Prestwick_711, Buspirone hydrochloride [USAN:USP], Buspar (TN), Opera_ID_707, AC1L1VQO, AC1Q3EKR, SCHEMBL41495, MLS001076085, MLS002548862, C21H31N5O2.HCl, Buspirone hydrochloride (USP), Jsp006125, CHEMBL1200399, DTXSID1037193, CTK8F8364, RICLFGYGYQXUFH-UHFFFAOYSA-N, HMS1569I19, Pharmakon1600-02300173, APC-6002, APC-6003, BCP28463, HY-B1115, Tox21_500223, NSC751138, NSC759571, s4256, AKOS015962019, AC-1905, CCG-213652, CS-4714, H05B847, KS-5163, LP00223, MCULE-3504513666, NC00673, NSC-751138, NSC-759571, VA10444, KS-000018A2, NCGC00093692-01, NCGC00093692-02, NCGC00260908-01, AN-14507, BC228667, CPD000058186, LS-22724, SAM002264597, EU-0100223, FT-0623290, ST51014924, SW155073-5, B 7148, D00702, J10144, K-7699, Q-200768, SR-01000075541-1, SR-01000075541-3, SR-01000075541-7, Buspirone Hydrochloride 1.0 mg/ml in Methanol (as free base), Buspirone hydrochloride, European Pharmacopoeia (EP) Reference Standard, Buspirone hydrochloride, United States Pharmacopeia (USP) Reference Standard, 8-[4-(4-pyrimidin-2-ylpiperazinyl)butyl]-8-azaspiro[4.5]decane-7,9-dione, chlo ride, 8-Azaspiro(4,5)decane-7,9-dione,8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl), 8-Azaspiro[4.5]decane-7, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride, Buspirone for system suitability, European Pharmacopoeia (EP) Reference Standard, Buspirone hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, N-[4-(4-[2-Pyrimidinyl]-1-piperazinyl)butyl]-8-azaspiro[4, 5]decane-7, 9-dione, 1-[4-(7,9-dioxo-8-azaspiro[4.5]decan-8-yl)butyl]-4-(pyrimidin-2-yl)piperazin-1-ium chloride, 8-[4-[4-(2-Pyrimidinyl)-1-pipirazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione hydrochloride, 8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione hydrochloride, 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-,monohydrochloride, Buspirone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, buspirone, Buparvaquone, Ansial, C21H31N5O2.ClH, CID36431, C21-H31-N5-O2.Cl-H, CS-O-03485, MJ-9022-1, B1687, A15687, 36505-84-7, 1,1-Cyclopentanediacetimide, N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione monohydrochloride, 8-Azaspiro [4.5] decano-7,9-diona, 8-[4-[4-(2-pirimidinil])-1-butil piperacinil]butil]-, clorhidrato de (1:1), 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited